Seno Medical Instruments' Imagio™ Opto-Acoustic Breast Imaging System Demonstrates Ability to Downgrade Risk Classification of Benign Breast Masses in a Prospective European Clinical Trial
29 November 2017
Seno Medical Instruments, Inc. (Seno Medical), the leader in new technology for breast cancer diagnosis using optoacoustic (OA/US) imaging to differentiate benign from malignant masses, today annou